(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services...
Stats | |
---|---|
Today's Volume | 529 130 |
Average Volume | 1.60M |
Market Cap | 7.88B |
EPS | INR0 ( 2024-02-13 ) |
Next earnings date | ( INR0 ) 2024-05-27 |
Last Dividend | INR0.0500 ( 2020-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 97.64 |
ATR14 | INR0.0620 (0.18%) |
Volume Correlation
Nectar Lifesciences Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nectar Lifesciences Correlation - Currency/Commodity
Nectar Lifesciences Financials
Annual | 2022 |
Revenue: | INR15.24B |
Gross Profit: | INR3.64B (23.91 %) |
EPS: | INR-1.080 |
FY | 2022 |
Revenue: | INR15.24B |
Gross Profit: | INR3.64B (23.91 %) |
EPS: | INR-1.080 |
FY | 2022 |
Revenue: | INR16.69B |
Gross Profit: | INR2.99B (17.94 %) |
EPS: | INR1.120 |
FY | 2021 |
Revenue: | INR15.43B |
Gross Profit: | INR2.58B (16.69 %) |
EPS: | INR-3.27 |
Financial Reports:
No articles found.
Nectar Lifesciences Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.100 | 2006-02-01 |
Last Dividend | INR0.0500 | 2020-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | INR1.900 | -- |
Avg. Dividend % Per Year | 0.05% | -- |
Score | 1.38 | -- |
Div. Sustainability Score | 1.879 | |
Div.Growth Potential Score | 2.79 | |
Div. Directional Score | 2.34 | -- |
Year | Amount | Yield |
---|---|---|
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0.0500 | 0.19% |
2019 | INR0.0500 | 0.24% |
2020 | INR0.100 | 0.81% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RPPL.NS | Dividend Junior | 2023-08-24 | Annually | 6 | 0.31% | |
LIKHITHA.NS | Dividend Junior | 2023-09-20 | Annually | 4 | 0.46% | |
GANESHHOUC.NS | Dividend Junior | 2023-08-31 | Sporadic | 18 | 0.18% | |
APTUS.NS | Dividend Junior | 2023-05-12 | Semi-Annually | 3 | 0.32% | |
TECHNOE.NS | Dividend Junior | 2023-09-15 | Annually | 16 | 1.13% | |
ONGC.NS | Dividend Knight | 2023-08-18 | Semi-Annually | 28 | 4.00% | |
IOC.NS | Dividend Knight | 2023-07-28 | Semi-Annually | 28 | 5.08% | |
CRAFTSMAN.NS | Dividend Junior | 2023-06-19 | Annually | 3 | 0.13% | |
SHANTIGEAR.NS | Dividend Junior | 2023-07-11 | Annually | 23 | 1.02% | |
MANGCHEFER.NS | Dividend Junior | 2023-09-18 | Annually | 17 | 1.18% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00493 | 1.500 | 9.90 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.00754 | 1.500 | -1.027 | -1.541 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 1.093 | 1.000 | -0.706 | -0.706 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.43 | 2.00 | 8.19 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.43 | 2.00 | 7.29 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.251 | 1.000 | 9.14 | 9.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0553 | 1.000 | -0.893 | -0.893 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.879 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 98.05 | 1.000 | 0.197 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00754 | 2.50 | -0.660 | -1.541 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.43 | 2.00 | 8.19 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.43 | 2.00 | 8.19 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.730 | 1.500 | 8.46 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0746 | 1.000 | -0.635 | 0 | [0.1 - 0.5] |
Total Score | 2.79 |
Nectar Lifesciences
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators